Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
Adam L. Halberstadt, Muhammad Chatha, Adam K. Klein, et al.
Neuropharmacology (2020) Vol. 167, pp. 107933-107933
Open Access | Times Cited: 187

Showing 1-25 of 187 citing articles:

Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider, Katrin H. Preller
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 611-624
Closed Access | Times Cited: 406
A non-hallucinogenic psychedelic analogue with therapeutic potential
Lindsay P. Cameron, Robert J. Tombari, Ju Lu, et al.
Nature (2020) Vol. 589, Iss. 7842, pp. 474-479
Open Access | Times Cited: 335
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
Natalie Hesselgrave, Timothy A. Troppoli, Andreas B. Wulff, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 17
Open Access | Times Cited: 259
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
Rafael Moliner, Mykhailo Girych, Cecilia A. Brunello, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 6, pp. 1032-1041
Open Access | Times Cited: 225
Designer drugs: mechanism of action and adverse effects
Dino Luethi, Matthias E. Liechti
Archives of Toxicology (2020) Vol. 94, Iss. 4, pp. 1085-1133
Open Access | Times Cited: 210
The neural basis of psychedelic action
Alex C. Kwan, David E. Olson, Katrin H. Preller, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 11, pp. 1407-1419
Closed Access | Times Cited: 166
Central 5-HT receptors and their function; present and future
Trevor Sharp, Nicholas M. Barnes
Neuropharmacology (2020) Vol. 177, pp. 108155-108155
Open Access | Times Cited: 158
Psychedelic-inspired drug discovery using an engineered biosensor
Chunyang Dong, Calvin Ly, Lee E. Dunlap, et al.
Cell (2021) Vol. 184, Iss. 10, pp. 2779-2792.e18
Open Access | Times Cited: 139
The promises and perils of psychedelic pharmacology for psychiatry
Tristan McClure‐Begley, Bryan L. Roth
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 6, pp. 463-473
Closed Access | Times Cited: 139
Psychedelics reopen the social reward learning critical period
Romain Nardou, Edward J. Sawyer, Young Jun Song, et al.
Nature (2023) Vol. 618, Iss. 7966, pp. 790-798
Open Access | Times Cited: 138
Psychedelics and Other Psychoplastogens for Treating Mental Illness
Maxemiliano V. Vargas, Retsina Meyer, Arabo A. Avanes, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 113
Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
David E. Olson
Biochemistry (2022) Vol. 61, Iss. 3, pp. 127-136
Open Access | Times Cited: 76
A non-hallucinogenic LSD analog with therapeutic potential for mood disorders
Vern Lewis, Emma M. Bonniwell, Janelle K. Lanham, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112203-112203
Open Access | Times Cited: 68
5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines
Lindsay P. Cameron, Seona D. Patel, Maxemiliano V. Vargas, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 351-358
Open Access | Times Cited: 56
Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential
Jason Wallach, Andrew B. Cao, Maggie M. Calkins, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?
Mehdi Sekssaoui, Joël Bockaert, Philippe Marin, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 4, pp. 747-756
Open Access | Times Cited: 22
Toxicodynamic insights of 2 C and NBOMe drugs – is there abuse potential?
Eva Gil-Martins, Daniel José Barbosa, Fernanda Borges, et al.
Toxicology Reports (2025) Vol. 14, pp. 101890-101890
Open Access | Times Cited: 1
Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications
Alberto Melani, Marco Bonaso, Letizia Biso, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 130-130
Open Access | Times Cited: 1
A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics
Neil K. Savalia, Ling-Xiao Shao, Alex C. Kwan
Trends in Neurosciences (2020) Vol. 44, Iss. 4, pp. 260-275
Open Access | Times Cited: 81
Investigation of the Structure–Activity Relationships of Psilocybin Analogues
Adam K. Klein, Muhammad Chatha, Lauren J. Laskowski, et al.
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 533-542
Open Access | Times Cited: 78
Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison
Pantelis Leptourgos, Martin Fortier-Davy, Robin Carhart‐Harris, et al.
Schizophrenia Bulletin (2020) Vol. 46, Iss. 6, pp. 1396-1408
Open Access | Times Cited: 75
Classic Psychedelic Drugs: Update on Biological Mechanisms
Franz X. Vollenweider, John Smallridge
Pharmacopsychiatry (2022) Vol. 55, Iss. 03, pp. 121-138
Open Access | Times Cited: 63
Psychedelics
Benjamin Kelmendi, Alfred P. Kaye, Christopher Pittenger, et al.
Current Biology (2022) Vol. 32, Iss. 2, pp. R63-R67
Open Access | Times Cited: 62
LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1
Ramona M. Rodriguiz, Vineet Nadkarni, Christopher R. Means, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 60
Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice
Grant C. Glatfelter, Eline Pottie, John S. Partilla, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 11, pp. 1181-1196
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top